skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 56  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 next page
Refined by: Database: Oxford Journals Open Access Collection remove Database: SWEPUB Freely available online remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
Material Type:
Article 		Add to My Research

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European heart journal, 2021-09, Vol.42 (36), p.3741-3752 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab499 ;PMID: 34392331

Full text available

Citations Cited by
2
Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance
Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance
Material Type:
Article 		Add to My Research

Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance

European heart journal, 2020-10, Vol.41 (39), p.3813-3823 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;info:eu-repo/semantics/openAccess ;Attribution - NonCommercial ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa603 ;PMID: 32918449

Full text available

Citations Cited by
3
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure
Material Type:
Article 		Add to My Research

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure

Europace (London, England), 2022-01, Vol.24 (1), p.48-57 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euab233 ;PMID: 34486653

Full text available

Citations Cited by
4
Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
Material Type:
Article 		Add to My Research

Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)

European heart journal, 2022-06, Vol.43 (23), p.2185-2195 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehac151 ;PMID: 35443059

Full text available

Citations Cited by
5
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry
Material Type:
Article 		Add to My Research

Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry

European heart journal. Cardiovascular pharmacotherapy, 2022-12, Vol.8 (8), p.756-767 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;COPYRIGHT 2022 Oxford University Press ;ISSN: 2055-6837 ;ISSN: 2055-6845 ;EISSN: 2055-6845 ;DOI: 10.1093/ehjcvp/pvab079 ;PMID: 34921603

Full text available

Citations Cited by
6
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Material Type:
Article 		Add to My Research

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Europace (London, England), 2016-01, Vol.18 (1), p.12-36 [Peer Reviewed Journal]

ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euv191 ;PMID: 26297713

Full text available

Citations Cited by
7
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Material Type:
Article 		Add to My Research

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

European heart journal, 2024-04, Vol.45 (14), p.1224-1240 [Peer Reviewed Journal]

The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024 ;The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehae105 ;PMID: 38441940

Digital Resources/Online E-Resources

Citations Cited by
8
Hypothetical 22-Year Intervention With the Dietary Approaches to Stop Hypertension and Risk of Heart Failure in a General Population
Hypothetical 22-Year Intervention With the Dietary Approaches to Stop Hypertension and Risk of Heart Failure in a General Population
Material Type:
Article 		Add to My Research

Hypothetical 22-Year Intervention With the Dietary Approaches to Stop Hypertension and Risk of Heart Failure in a General Population

American journal of epidemiology, 2024-01, Vol.193 (1), p.96-106 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. ;ISSN: 0002-9262 ;ISSN: 1476-6256 ;EISSN: 1476-6256 ;DOI: 10.1093/aje/kwad181 ;PMID: 37656615

Digital Resources/Online E-Resources

Citations Cited by
9
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon
Material Type:
Article 		Add to My Research

Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon

Europace (London, England), 2013-10, Vol.15 (10), p.1453-1462 [Peer Reviewed Journal]

ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/eut133 ;PMID: 23696624

Full text available

Citations Cited by
10
PGC-1α deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice
PGC-1α deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice
Material Type:
Article 		Add to My Research

PGC-1α deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice

Cardiovascular research, 2022-05, Vol.118 (6), p.1520-1534 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0008-6363 ;ISSN: 1755-3245 ;EISSN: 1755-3245 ;DOI: 10.1093/cvr/cvab188 ;PMID: 34086875

Full text available

Citations Cited by
11
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Material Type:
Article 		Add to My Research

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Europace (London, England), 2022-01, Vol.24 (1), p.71-164 [Peer Reviewed Journal]

This article has been co-published with permission in the European Heart Journal and EP Europace . © the European Society of Cardiology 2021. All rights reserved. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article. For permissions, please email journals.permissions@oup.com. 2021 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euab232 ;PMID: 34455427

Full text available

Citations Cited by
12
Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality
Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality
Material Type:
Article 		Add to My Research

Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality

Europace (London, England), 2014-11, Vol.16 (11), p.1603-1609 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com. ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euu058 ;PMID: 24681763

Full text available

Citations Cited by
13
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study
Material Type:
Article 		Add to My Research

Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal study

European heart journal. Acute cardiovascular care, 2023-05, Vol.12 (5), p.315-327 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 2048-8726 ;ISSN: 2048-8734 ;EISSN: 2048-8734 ;DOI: 10.1093/ehjacc/zuad020 ;PMID: 36888552

Full text available

Citations Cited by
14
P05-04 Physical activity level and sedentary time prior to cardiac ward admission among patients with cardiovascular disease and its association to all-cause mortality
P05-04 Physical activity level and sedentary time prior to cardiac ward admission among patients with cardiovascular disease and its association to all-cause mortality
Material Type:
Article 		Add to My Research

P05-04 Physical activity level and sedentary time prior to cardiac ward admission among patients with cardiovascular disease and its association to all-cause mortality

EUROPEAN JOURNAL OF PUBLIC HEALTH, vol. 32, S2, 2022-09, Vol.32 (Supplement_2) [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. ;ISSN: 1101-1262 ;EISSN: 1464-360X ;DOI: 10.1093/eurpub/ckac095.071

Full text available

Citations Cited by
15
The role of imaging in the selection of patients for HFpEF therapy
The role of imaging in the selection of patients for HFpEF therapy
Material Type:
Article 		Add to My Research

The role of imaging in the selection of patients for HFpEF therapy

European heart journal cardiovascular imaging, 2023-09, Vol.24 (10), p.1343-1351 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;ISSN: 2047-2404 ;ISSN: 2047-2412 ;EISSN: 2047-2412 ;DOI: 10.1093/ehjci/jead137

Digital Resources/Online E-Resources

Citations Cited by
16
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation
Material Type:
Article 		Add to My Research

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation

Europace (London, England), 2019-12, Vol.21 (12), p.1764-1775 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euz193 ;PMID: 31324921

Full text available

Citations Cited by
17
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey
Material Type:
Article 		Add to My Research

The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey

Europace (London, England), 2018-06, Vol.20 (6), p.929-934 [Peer Reviewed Journal]

ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/eux217 ;PMID: 29016989

Full text available

Citations Cited by
18
European cardiac resynchronization therapy survey II: rationale and design
European cardiac resynchronization therapy survey II: rationale and design
Material Type:
Article 		Add to My Research

European cardiac resynchronization therapy survey II: rationale and design

Europace (London, England), 2015-01, Vol.17 (1), p.137-141 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com. ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euu312 ;PMID: 25414481

Full text available

Citations Cited by
19
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
Material Type:
Article 		Add to My Research

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

Europace (London, England), 2023-01, Vol.25 (1), p.6-27 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. 2022 ;ISSN: 1099-5129 ;ISSN: 1532-2092 ;EISSN: 1532-2092 ;DOI: 10.1093/europace/euac062 ;PMID: 35894842

Full text available

Citations Cited by
20
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial
Material Type:
Article 		Add to My Research

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial

European heart journal, 2023-12, Vol.44 (48), p.5163-5166 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehad639 ;PMID: 37864578

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 56  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2011  (3)
  2. 2011 To 2014  (5)
  3. 2015 To 2018  (7)
  4. 2019 To 2022  (22)
  5. After 2022  (20)
  6. More options open sub menu

Language 

  1. Japanese  (5)
  2. Norwegian  (2)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait